Adar1 Capital Management, LLC Aerovate Therapeutics, Inc. Call Options Transaction History
Adar1 Capital Management, LLC
- $652 Billion
- Q2 2025
Call Options
1 transactions
Others Institutions Holding AVTE
# of Institutions
6Shares Held
1.73MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY983KShares$2.63 Million0.0% of portfolio
-
Oup Management Co., LLC604KShares$1.62 Million18.43% of portfolio
-
Jpmorgan Chase & CO New York, NY75.7KShares$202,8060.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL40KShares$107,3250.0% of portfolio
-
Kovitz Investment Group Partners, LLC24.2KShares$64,8820.0% of portfolio
About Aerovate Therapeutics, Inc.
- Ticker AVTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,448,100
- Market Cap $65.5M
- Description
- Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...